nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorouracil—MTHFR—uterine cancer	0.356	1	CbGaD
Fluorouracil—ABCC3—Etoposide—uterine cancer	0.0487	0.135	CbGbCtD
Fluorouracil—CYP2A6—Progesterone—uterine cancer	0.0483	0.133	CbGbCtD
Fluorouracil—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.036	0.0993	CbGbCtD
Fluorouracil—ABCG2—Dactinomycin—uterine cancer	0.0355	0.098	CbGbCtD
Fluorouracil—ABCC3—Doxorubicin—uterine cancer	0.0332	0.0918	CbGbCtD
Fluorouracil—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0251	0.0693	CbGbCtD
Fluorouracil—ABCG2—Carboplatin—uterine cancer	0.0238	0.0658	CbGbCtD
Fluorouracil—CYP2C8—Progesterone—uterine cancer	0.0238	0.0658	CbGbCtD
Fluorouracil—ABCG2—Etoposide—uterine cancer	0.02	0.0553	CbGbCtD
Fluorouracil—CYP1A2—Progesterone—uterine cancer	0.0184	0.0509	CbGbCtD
Fluorouracil—CYP2C9—Progesterone—uterine cancer	0.0166	0.0459	CbGbCtD
Fluorouracil—ABCG2—Doxorubicin—uterine cancer	0.0136	0.0377	CbGbCtD
Fluorouracil—CYP2C8—Etoposide—uterine cancer	0.0107	0.0294	CbGbCtD
Fluorouracil—CYP1A2—Etoposide—uterine cancer	0.00825	0.0228	CbGbCtD
Fluorouracil—UPP2—renal system—uterine cancer	0.00319	0.0417	CbGeAlD
Fluorouracil—UPP1—myometrium—uterine cancer	0.00228	0.0298	CbGeAlD
Fluorouracil—MTHFR—artery—uterine cancer	0.00208	0.0273	CbGeAlD
Fluorouracil—UMPS—uterine cervix—uterine cancer	0.00193	0.0253	CbGeAlD
Fluorouracil—UMPS—decidua—uterine cancer	0.00184	0.0241	CbGeAlD
Fluorouracil—UPP1—uterine cervix—uterine cancer	0.00177	0.0232	CbGeAlD
Fluorouracil—UPP1—decidua—uterine cancer	0.00169	0.0221	CbGeAlD
Fluorouracil—UMPS—uterus—uterine cancer	0.00161	0.0211	CbGeAlD
Fluorouracil—UPP1—endometrium—uterine cancer	0.0016	0.021	CbGeAlD
Fluorouracil—PPAT—myometrium—uterine cancer	0.0016	0.021	CbGeAlD
Fluorouracil—UPP1—mammalian vulva—uterine cancer	0.00155	0.0203	CbGeAlD
Fluorouracil—UPP1—uterus—uterine cancer	0.00148	0.0193	CbGeAlD
Fluorouracil—UMPS—female reproductive system—uterine cancer	0.00145	0.019	CbGeAlD
Fluorouracil—DPYD—uterine cervix—uterine cancer	0.00144	0.0188	CbGeAlD
Fluorouracil—DPYD—decidua—uterine cancer	0.00137	0.018	CbGeAlD
Fluorouracil—UPP1—female reproductive system—uterine cancer	0.00133	0.0174	CbGeAlD
Fluorouracil—UMPS—female gonad—uterine cancer	0.00132	0.0173	CbGeAlD
Fluorouracil—UMPS—vagina—uterine cancer	0.00131	0.0172	CbGeAlD
Fluorouracil—PPAT—uterine cervix—uterine cancer	0.00125	0.0163	CbGeAlD
Fluorouracil—UPP1—female gonad—uterine cancer	0.00121	0.0158	CbGeAlD
Fluorouracil—UPP1—vagina—uterine cancer	0.0012	0.0157	CbGeAlD
Fluorouracil—DPYD—uterus—uterine cancer	0.0012	0.0157	CbGeAlD
Fluorouracil—PPAT—endometrium—uterine cancer	0.00113	0.0148	CbGeAlD
Fluorouracil—PPAT—mammalian vulva—uterine cancer	0.00109	0.0143	CbGeAlD
Fluorouracil—TYMP—myometrium—uterine cancer	0.00107	0.014	CbGeAlD
Fluorouracil—DPYD—female gonad—uterine cancer	0.000981	0.0128	CbGeAlD
Fluorouracil—PPAT—female reproductive system—uterine cancer	0.000933	0.0122	CbGeAlD
Fluorouracil—PPAT—female gonad—uterine cancer	0.000849	0.0111	CbGeAlD
Fluorouracil—UMPS—lymph node—uterine cancer	0.000847	0.0111	CbGeAlD
Fluorouracil—PPAT—vagina—uterine cancer	0.000844	0.0111	CbGeAlD
Fluorouracil—TYMP—uterine cervix—uterine cancer	0.000834	0.0109	CbGeAlD
Fluorouracil—SLC29A1—myometrium—uterine cancer	0.000824	0.0108	CbGeAlD
Fluorouracil—TYMP—smooth muscle tissue—uterine cancer	0.00081	0.0106	CbGeAlD
Fluorouracil—TYMP—decidua—uterine cancer	0.000794	0.0104	CbGeAlD
Fluorouracil—SLC22A7—renal system—uterine cancer	0.000778	0.0102	CbGeAlD
Fluorouracil—UPP1—lymph node—uterine cancer	0.000777	0.0102	CbGeAlD
Fluorouracil—TYMP—endometrium—uterine cancer	0.000754	0.00987	CbGeAlD
Fluorouracil—TYMP—mammalian vulva—uterine cancer	0.000729	0.00955	CbGeAlD
Fluorouracil—TYMS—uterine cervix—uterine cancer	0.000715	0.00937	CbGeAlD
Fluorouracil—ABCC5—uterine cervix—uterine cancer	0.000699	0.00915	CbGeAlD
Fluorouracil—TYMS—smooth muscle tissue—uterine cancer	0.000695	0.0091	CbGeAlD
Fluorouracil—TYMP—uterus—uterine cancer	0.000695	0.0091	CbGeAlD
Fluorouracil—ABCC5—decidua—uterine cancer	0.000666	0.00872	CbGeAlD
Fluorouracil—TYMS—endometrium—uterine cancer	0.000647	0.00847	CbGeAlD
Fluorouracil—SLC29A1—uterine cervix—uterine cancer	0.000641	0.0084	CbGeAlD
Fluorouracil—DPYD—lymph node—uterine cancer	0.000631	0.00826	CbGeAlD
Fluorouracil—TYMS—mammalian vulva—uterine cancer	0.000626	0.0082	CbGeAlD
Fluorouracil—TYMP—female reproductive system—uterine cancer	0.000625	0.00818	CbGeAlD
Fluorouracil—SLC29A1—decidua—uterine cancer	0.000611	0.008	CbGeAlD
Fluorouracil—SLC29A1—renal system—uterine cancer	0.0006	0.00786	CbGeAlD
Fluorouracil—MTHFR—female reproductive system—uterine cancer	0.000587	0.00769	CbGeAlD
Fluorouracil—SLC29A1—endometrium—uterine cancer	0.00058	0.0076	CbGeAlD
Fluorouracil—TYMP—female gonad—uterine cancer	0.000568	0.00744	CbGeAlD
Fluorouracil—TYMP—vagina—uterine cancer	0.000565	0.0074	CbGeAlD
Fluorouracil—SLC29A1—mammalian vulva—uterine cancer	0.000561	0.00735	CbGeAlD
Fluorouracil—ABCC3—decidua—uterine cancer	0.000559	0.00732	CbGeAlD
Fluorouracil—ABCC3—renal system—uterine cancer	0.000549	0.00719	CbGeAlD
Fluorouracil—PPAT—lymph node—uterine cancer	0.000546	0.00715	CbGeAlD
Fluorouracil—TYMS—female reproductive system—uterine cancer	0.000536	0.00702	CbGeAlD
Fluorouracil—SLC29A1—uterus—uterine cancer	0.000535	0.007	CbGeAlD
Fluorouracil—MTHFR—female gonad—uterine cancer	0.000534	0.007	CbGeAlD
Fluorouracil—UMPS—Idarubicin—Epirubicin—uterine cancer	0.000499	0.15	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Epirubicin—uterine cancer	0.000499	0.15	CbGdCrCtD
Fluorouracil—UMPS—Doxorubicin—Epirubicin—uterine cancer	0.000499	0.15	CbGdCrCtD
Fluorouracil—TYMS—female gonad—uterine cancer	0.000488	0.00639	CbGeAlD
Fluorouracil—TYMS—vagina—uterine cancer	0.000485	0.00635	CbGeAlD
Fluorouracil—SLC29A1—female reproductive system—uterine cancer	0.000481	0.00629	CbGeAlD
Fluorouracil—ABCC5—female gonad—uterine cancer	0.000476	0.00624	CbGeAlD
Fluorouracil—ABCC5—vagina—uterine cancer	0.000473	0.0062	CbGeAlD
Fluorouracil—UMPS—Idarubicin—Doxorubicin—uterine cancer	0.000461	0.139	CbGdCrCtD
Fluorouracil—UMPS—Daunorubicin—Doxorubicin—uterine cancer	0.000461	0.139	CbGdCrCtD
Fluorouracil—UMPS—Epirubicin—Doxorubicin—uterine cancer	0.000461	0.139	CbGdCrCtD
Fluorouracil—ABCC4—renal system—uterine cancer	0.000453	0.00593	CbGeAlD
Fluorouracil—ABCC3—female reproductive system—uterine cancer	0.00044	0.00576	CbGeAlD
Fluorouracil—ABCG2—myometrium—uterine cancer	0.000439	0.00575	CbGeAlD
Fluorouracil—SLC29A1—female gonad—uterine cancer	0.000437	0.00573	CbGeAlD
Fluorouracil—SLC29A1—vagina—uterine cancer	0.000435	0.00569	CbGeAlD
Fluorouracil—CYP2A6—vagina—uterine cancer	0.000424	0.00556	CbGeAlD
Fluorouracil—ABCC4—uterus—uterine cancer	0.000404	0.00529	CbGeAlD
Fluorouracil—ABCC3—female gonad—uterine cancer	0.0004	0.00524	CbGeAlD
Fluorouracil—TYMP—lymph node—uterine cancer	0.000365	0.00479	CbGeAlD
Fluorouracil—ABCC4—female reproductive system—uterine cancer	0.000363	0.00475	CbGeAlD
Fluorouracil—MTHFR—lymph node—uterine cancer	0.000344	0.0045	CbGeAlD
Fluorouracil—ABCG2—uterine cervix—uterine cancer	0.000342	0.00448	CbGeAlD
Fluorouracil—ABCC4—female gonad—uterine cancer	0.00033	0.00432	CbGeAlD
Fluorouracil—CYP2C8—renal system—uterine cancer	0.000329	0.00431	CbGeAlD
Fluorouracil—ABCG2—decidua—uterine cancer	0.000326	0.00427	CbGeAlD
Fluorouracil—CYP2C8—endometrium—uterine cancer	0.000318	0.00416	CbGeAlD
Fluorouracil—TYMS—lymph node—uterine cancer	0.000313	0.00411	CbGeAlD
Fluorouracil—ABCG2—endometrium—uterine cancer	0.000309	0.00405	CbGeAlD
Fluorouracil—CYP1A2—renal system—uterine cancer	0.000308	0.00403	CbGeAlD
Fluorouracil—ABCC5—lymph node—uterine cancer	0.000306	0.00401	CbGeAlD
Fluorouracil—ABCG2—mammalian vulva—uterine cancer	0.000299	0.00392	CbGeAlD
Fluorouracil—ABCG2—uterus—uterine cancer	0.000285	0.00373	CbGeAlD
Fluorouracil—SLC29A1—lymph node—uterine cancer	0.000281	0.00368	CbGeAlD
Fluorouracil—CYP2C8—female reproductive system—uterine cancer	0.000263	0.00345	CbGeAlD
Fluorouracil—ABCC3—lymph node—uterine cancer	0.000257	0.00337	CbGeAlD
Fluorouracil—TYMS—Podofilox—Etoposide—uterine cancer	0.000239	0.0718	CbGdCrCtD
Fluorouracil—CYP2C8—vagina—uterine cancer	0.000238	0.00312	CbGeAlD
Fluorouracil—CYP2C9—female reproductive system—uterine cancer	0.000234	0.00306	CbGeAlD
Fluorouracil—ABCG2—female gonad—uterine cancer	0.000233	0.00305	CbGeAlD
Fluorouracil—ABCG2—vagina—uterine cancer	0.000232	0.00303	CbGeAlD
Fluorouracil—ALB—lymph node—uterine cancer	0.000219	0.00287	CbGeAlD
Fluorouracil—ABCC4—lymph node—uterine cancer	0.000212	0.00278	CbGeAlD
Fluorouracil—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000184	0.00141	CcSEcCtD
Fluorouracil—Cellulitis—Doxorubicin—uterine cancer	0.000184	0.00141	CcSEcCtD
Fluorouracil—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000183	0.0014	CcSEcCtD
Fluorouracil—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00139	CcSEcCtD
Fluorouracil—Herpes simplex—Doxorubicin—uterine cancer	0.000181	0.00139	CcSEcCtD
Fluorouracil—Lacrimation increased—Doxorubicin—uterine cancer	0.000181	0.00139	CcSEcCtD
Fluorouracil—Pneumonia—Etoposide—uterine cancer	0.000181	0.00139	CcSEcCtD
Fluorouracil—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000181	0.00139	CcSEcCtD
Fluorouracil—Infestation NOS—Etoposide—uterine cancer	0.00018	0.00138	CcSEcCtD
Fluorouracil—Infestation—Etoposide—uterine cancer	0.00018	0.00138	CcSEcCtD
Fluorouracil—Anaemia—Dactinomycin—uterine cancer	0.00018	0.00138	CcSEcCtD
Fluorouracil—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000179	0.00138	CcSEcCtD
Fluorouracil—Urticaria—Progesterone—uterine cancer	0.000178	0.00137	CcSEcCtD
Fluorouracil—Dermatitis contact—Epirubicin—uterine cancer	0.000178	0.00137	CcSEcCtD
Fluorouracil—Acute coronary syndrome—Etoposide—uterine cancer	0.000177	0.00136	CcSEcCtD
Fluorouracil—Body temperature increased—Progesterone—uterine cancer	0.000177	0.00136	CcSEcCtD
Fluorouracil—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000177	0.00136	CcSEcCtD
Fluorouracil—Dysarthria—Doxorubicin—uterine cancer	0.000176	0.00136	CcSEcCtD
Fluorouracil—Ulcer—Doxorubicin—uterine cancer	0.000176	0.00136	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Etoposide—uterine cancer	0.000176	0.00136	CcSEcCtD
Fluorouracil—Myocardial infarction—Etoposide—uterine cancer	0.000176	0.00136	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000176	0.00135	CcSEcCtD
Fluorouracil—Stomatitis—Etoposide—uterine cancer	0.000175	0.00135	CcSEcCtD
Fluorouracil—Leukopenia—Dactinomycin—uterine cancer	0.000174	0.00134	CcSEcCtD
Fluorouracil—Inflammation—Doxorubicin—uterine cancer	0.000172	0.00132	CcSEcCtD
Fluorouracil—Agranulocytosis—Etoposide—uterine cancer	0.000168	0.00129	CcSEcCtD
Fluorouracil—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000168	0.00129	CcSEcCtD
Fluorouracil—Myalgia—Dactinomycin—uterine cancer	0.000165	0.00127	CcSEcCtD
Fluorouracil—Hypersensitivity—Progesterone—uterine cancer	0.000165	0.00127	CcSEcCtD
Fluorouracil—Dermatitis contact—Doxorubicin—uterine cancer	0.000165	0.00127	CcSEcCtD
Fluorouracil—Oesophagitis—Epirubicin—uterine cancer	0.000165	0.00127	CcSEcCtD
Fluorouracil—Coma—Epirubicin—uterine cancer	0.000165	0.00127	CcSEcCtD
Fluorouracil—Rash maculo-papular—Epirubicin—uterine cancer	0.000164	0.00126	CcSEcCtD
Fluorouracil—Discomfort—Dactinomycin—uterine cancer	0.000163	0.00126	CcSEcCtD
Fluorouracil—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000162	0.00124	CcSEcCtD
Fluorouracil—Hypoaesthesia—Etoposide—uterine cancer	0.000161	0.00124	CcSEcCtD
Fluorouracil—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000161	0.00124	CcSEcCtD
Fluorouracil—Pruritus—Progesterone—uterine cancer	0.000159	0.00122	CcSEcCtD
Fluorouracil—Oedema—Dactinomycin—uterine cancer	0.000159	0.00122	CcSEcCtD
Fluorouracil—Infection—Dactinomycin—uterine cancer	0.000158	0.00121	CcSEcCtD
Fluorouracil—Sepsis—Epirubicin—uterine cancer	0.000157	0.0012	CcSEcCtD
Fluorouracil—Thrombocytopenia—Dactinomycin—uterine cancer	0.000155	0.00119	CcSEcCtD
Fluorouracil—Diarrhoea—Progesterone—uterine cancer	0.000154	0.00118	CcSEcCtD
Fluorouracil—Coma—Doxorubicin—uterine cancer	0.000152	0.00117	CcSEcCtD
Fluorouracil—Oesophagitis—Doxorubicin—uterine cancer	0.000152	0.00117	CcSEcCtD
Fluorouracil—Rash maculo-papular—Doxorubicin—uterine cancer	0.000152	0.00117	CcSEcCtD
Fluorouracil—Thrombophlebitis—Epirubicin—uterine cancer	0.000151	0.00116	CcSEcCtD
Fluorouracil—Anorexia—Dactinomycin—uterine cancer	0.000151	0.00116	CcSEcCtD
Fluorouracil—ABCG2—lymph node—uterine cancer	0.00015	0.00196	CbGeAlD
Fluorouracil—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00015	0.00115	CcSEcCtD
Fluorouracil—Photosensitivity—Epirubicin—uterine cancer	0.000149	0.00115	CcSEcCtD
Fluorouracil—Dizziness—Progesterone—uterine cancer	0.000148	0.00114	CcSEcCtD
Fluorouracil—Sepsis—Doxorubicin—uterine cancer	0.000145	0.00111	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000145	0.00111	CcSEcCtD
Fluorouracil—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000144	0.00111	CcSEcCtD
Fluorouracil—Alopecia—Etoposide—uterine cancer	0.000143	0.0011	CcSEcCtD
Fluorouracil—Vomiting—Progesterone—uterine cancer	0.000143	0.0011	CcSEcCtD
Fluorouracil—Rash—Progesterone—uterine cancer	0.000141	0.00109	CcSEcCtD
Fluorouracil—Dermatitis—Progesterone—uterine cancer	0.000141	0.00109	CcSEcCtD
Fluorouracil—Headache—Progesterone—uterine cancer	0.000141	0.00108	CcSEcCtD
Fluorouracil—Thrombophlebitis—Doxorubicin—uterine cancer	0.00014	0.00108	CcSEcCtD
Fluorouracil—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000139	0.00107	CcSEcCtD
Fluorouracil—Photosensitivity—Doxorubicin—uterine cancer	0.000138	0.00106	CcSEcCtD
Fluorouracil—Decreased appetite—Dactinomycin—uterine cancer	0.000138	0.00106	CcSEcCtD
Fluorouracil—Dermatitis bullous—Epirubicin—uterine cancer	0.000137	0.00105	CcSEcCtD
Fluorouracil—Pain—Dactinomycin—uterine cancer	0.000136	0.00104	CcSEcCtD
Fluorouracil—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000134	0.00103	CcSEcCtD
Fluorouracil—Cardiac failure—Epirubicin—uterine cancer	0.000134	0.00103	CcSEcCtD
Fluorouracil—Lethargy—Epirubicin—uterine cancer	0.000134	0.00103	CcSEcCtD
Fluorouracil—Nausea—Progesterone—uterine cancer	0.000133	0.00102	CcSEcCtD
Fluorouracil—Osteoarthritis—Epirubicin—uterine cancer	0.000131	0.00101	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000131	0.00101	CcSEcCtD
Fluorouracil—Feeling abnormal—Dactinomycin—uterine cancer	0.000131	0.001	CcSEcCtD
Fluorouracil—Anaemia—Etoposide—uterine cancer	0.00013	0.000999	CcSEcCtD
Fluorouracil—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000129	0.000994	CcSEcCtD
Fluorouracil—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000128	0.000985	CcSEcCtD
Fluorouracil—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000128	0.000985	CcSEcCtD
Fluorouracil—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000127	0.000979	CcSEcCtD
Fluorouracil—Dermatitis bullous—Doxorubicin—uterine cancer	0.000127	0.000974	CcSEcCtD
Fluorouracil—Leukopenia—Etoposide—uterine cancer	0.000126	0.000968	CcSEcCtD
Fluorouracil—Body temperature increased—Dactinomycin—uterine cancer	0.000125	0.000964	CcSEcCtD
Fluorouracil—Cardiac arrest—Epirubicin—uterine cancer	0.000124	0.000957	CcSEcCtD
Fluorouracil—Cardiac failure—Doxorubicin—uterine cancer	0.000124	0.000954	CcSEcCtD
Fluorouracil—Lethargy—Doxorubicin—uterine cancer	0.000124	0.00095	CcSEcCtD
Fluorouracil—Ataxia—Epirubicin—uterine cancer	0.000123	0.000946	CcSEcCtD
Fluorouracil—TYMS—Danazol—Progesterone—uterine cancer	0.000123	0.0369	CbGdCrCtD
Fluorouracil—Convulsion—Etoposide—uterine cancer	0.000122	0.000937	CcSEcCtD
Fluorouracil—Osteoarthritis—Doxorubicin—uterine cancer	0.000121	0.000931	CcSEcCtD
Fluorouracil—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000121	0.000931	CcSEcCtD
Fluorouracil—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000121	0.000928	CcSEcCtD
Fluorouracil—Dry skin—Epirubicin—uterine cancer	0.00012	0.000922	CcSEcCtD
Fluorouracil—Chest pain—Etoposide—uterine cancer	0.00012	0.00092	CcSEcCtD
Fluorouracil—Discomfort—Etoposide—uterine cancer	0.000118	0.000909	CcSEcCtD
Fluorouracil—Nasopharyngitis—Epirubicin—uterine cancer	0.000117	0.0009	CcSEcCtD
Fluorouracil—Hypersensitivity—Dactinomycin—uterine cancer	0.000117	0.000898	CcSEcCtD
Fluorouracil—Confusional state—Etoposide—uterine cancer	0.000116	0.00089	CcSEcCtD
Fluorouracil—Muscular weakness—Epirubicin—uterine cancer	0.000115	0.000888	CcSEcCtD
Fluorouracil—Cardiac arrest—Doxorubicin—uterine cancer	0.000115	0.000885	CcSEcCtD
Fluorouracil—Anaphylactic shock—Etoposide—uterine cancer	0.000115	0.000882	CcSEcCtD
Fluorouracil—Infection—Etoposide—uterine cancer	0.000114	0.000877	CcSEcCtD
Fluorouracil—Ataxia—Doxorubicin—uterine cancer	0.000114	0.000876	CcSEcCtD
Fluorouracil—Dysphagia—Epirubicin—uterine cancer	0.000113	0.00087	CcSEcCtD
Fluorouracil—Thrombocytopenia—Etoposide—uterine cancer	0.000112	0.000864	CcSEcCtD
Fluorouracil—Tachycardia—Etoposide—uterine cancer	0.000112	0.000861	CcSEcCtD
Fluorouracil—Eosinophilia—Epirubicin—uterine cancer	0.000112	0.000861	CcSEcCtD
Fluorouracil—Dry skin—Doxorubicin—uterine cancer	0.000111	0.000853	CcSEcCtD
Fluorouracil—Angina pectoris—Epirubicin—uterine cancer	0.00011	0.000847	CcSEcCtD
Fluorouracil—Anorexia—Etoposide—uterine cancer	0.000109	0.000841	CcSEcCtD
Fluorouracil—Diarrhoea—Dactinomycin—uterine cancer	0.000109	0.000834	CcSEcCtD
Fluorouracil—Nasopharyngitis—Doxorubicin—uterine cancer	0.000108	0.000833	CcSEcCtD
Fluorouracil—Pancytopenia—Epirubicin—uterine cancer	0.000107	0.000826	CcSEcCtD
Fluorouracil—Hypotension—Etoposide—uterine cancer	0.000107	0.000824	CcSEcCtD
Fluorouracil—Muscular weakness—Doxorubicin—uterine cancer	0.000107	0.000821	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000105	0.000808	CcSEcCtD
Fluorouracil—Dysphagia—Doxorubicin—uterine cancer	0.000105	0.000805	CcSEcCtD
Fluorouracil—Eosinophilia—Doxorubicin—uterine cancer	0.000104	0.000797	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Epirubicin—uterine cancer	0.000103	0.000794	CcSEcCtD
Fluorouracil—Paraesthesia—Etoposide—uterine cancer	0.000103	0.000792	CcSEcCtD
Fluorouracil—Dyspnoea—Etoposide—uterine cancer	0.000102	0.000787	CcSEcCtD
Fluorouracil—Somnolence—Etoposide—uterine cancer	0.000102	0.000784	CcSEcCtD
Fluorouracil—Angina pectoris—Doxorubicin—uterine cancer	0.000102	0.000784	CcSEcCtD
Fluorouracil—Pneumonia—Epirubicin—uterine cancer	0.000101	0.00078	CcSEcCtD
Fluorouracil—Infestation NOS—Epirubicin—uterine cancer	0.000101	0.000775	CcSEcCtD
Fluorouracil—Infestation—Epirubicin—uterine cancer	0.000101	0.000775	CcSEcCtD
Fluorouracil—Vomiting—Dactinomycin—uterine cancer	0.000101	0.000775	CcSEcCtD
Fluorouracil—Rash—Dactinomycin—uterine cancer	0.0001	0.000769	CcSEcCtD
Fluorouracil—Decreased appetite—Etoposide—uterine cancer	9.98e-05	0.000767	CcSEcCtD
Fluorouracil—Pancytopenia—Doxorubicin—uterine cancer	9.94e-05	0.000764	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Etoposide—uterine cancer	9.91e-05	0.000762	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Epirubicin—uterine cancer	9.89e-05	0.00076	CcSEcCtD
Fluorouracil—Stomatitis—Epirubicin—uterine cancer	9.83e-05	0.000756	CcSEcCtD
Fluorouracil—Pain—Etoposide—uterine cancer	9.82e-05	0.000755	CcSEcCtD
Fluorouracil—Urinary tract infection—Epirubicin—uterine cancer	9.81e-05	0.000754	CcSEcCtD
Fluorouracil—Conjunctivitis—Epirubicin—uterine cancer	9.81e-05	0.000754	CcSEcCtD
Fluorouracil—Upper respiratory tract infection—Doxorubicin—uterine cancer	9.73e-05	0.000748	CcSEcCtD
Fluorouracil—Photosensitivity reaction—Doxorubicin—uterine cancer	9.56e-05	0.000735	CcSEcCtD
Fluorouracil—Epistaxis—Epirubicin—uterine cancer	9.52e-05	0.000731	CcSEcCtD
Fluorouracil—Sinusitis—Epirubicin—uterine cancer	9.47e-05	0.000728	CcSEcCtD
Fluorouracil—Feeling abnormal—Etoposide—uterine cancer	9.46e-05	0.000727	CcSEcCtD
Fluorouracil—Nausea—Dactinomycin—uterine cancer	9.42e-05	0.000724	CcSEcCtD
Fluorouracil—Agranulocytosis—Epirubicin—uterine cancer	9.42e-05	0.000724	CcSEcCtD
Fluorouracil—Pneumonia—Doxorubicin—uterine cancer	9.39e-05	0.000722	CcSEcCtD
Fluorouracil—Infestation NOS—Doxorubicin—uterine cancer	9.34e-05	0.000718	CcSEcCtD
Fluorouracil—Infestation—Doxorubicin—uterine cancer	9.34e-05	0.000718	CcSEcCtD
Fluorouracil—Neuropathy peripheral—Doxorubicin—uterine cancer	9.15e-05	0.000703	CcSEcCtD
Fluorouracil—Urticaria—Etoposide—uterine cancer	9.12e-05	0.000701	CcSEcCtD
Fluorouracil—Haemoglobin—Epirubicin—uterine cancer	9.1e-05	0.0007	CcSEcCtD
Fluorouracil—Stomatitis—Doxorubicin—uterine cancer	9.1e-05	0.000699	CcSEcCtD
Fluorouracil—Rhinitis—Epirubicin—uterine cancer	9.08e-05	0.000698	CcSEcCtD
Fluorouracil—Body temperature increased—Etoposide—uterine cancer	9.08e-05	0.000698	CcSEcCtD
Fluorouracil—Urinary tract infection—Doxorubicin—uterine cancer	9.07e-05	0.000697	CcSEcCtD
Fluorouracil—Conjunctivitis—Doxorubicin—uterine cancer	9.07e-05	0.000697	CcSEcCtD
Fluorouracil—Haemorrhage—Epirubicin—uterine cancer	9.06e-05	0.000696	CcSEcCtD
Fluorouracil—Hypoaesthesia—Epirubicin—uterine cancer	9.01e-05	0.000693	CcSEcCtD
Fluorouracil—Pharyngitis—Epirubicin—uterine cancer	8.99e-05	0.000691	CcSEcCtD
Fluorouracil—TYMS—Levonorgestrel—Progesterone—uterine cancer	8.82e-05	0.0265	CbGdCrCtD
Fluorouracil—Epistaxis—Doxorubicin—uterine cancer	8.81e-05	0.000677	CcSEcCtD
Fluorouracil—Sinusitis—Doxorubicin—uterine cancer	8.76e-05	0.000673	CcSEcCtD
Fluorouracil—Agranulocytosis—Doxorubicin—uterine cancer	8.71e-05	0.00067	CcSEcCtD
Fluorouracil—Hypersensitivity—Etoposide—uterine cancer	8.46e-05	0.00065	CcSEcCtD
Fluorouracil—Haemoglobin—Doxorubicin—uterine cancer	8.42e-05	0.000647	CcSEcCtD
Fluorouracil—Rhinitis—Doxorubicin—uterine cancer	8.4e-05	0.000646	CcSEcCtD
Fluorouracil—Haemorrhage—Doxorubicin—uterine cancer	8.38e-05	0.000644	CcSEcCtD
Fluorouracil—Hypoaesthesia—Doxorubicin—uterine cancer	8.34e-05	0.000641	CcSEcCtD
Fluorouracil—Pharyngitis—Doxorubicin—uterine cancer	8.32e-05	0.000639	CcSEcCtD
Fluorouracil—Pruritus—Etoposide—uterine cancer	8.12e-05	0.000624	CcSEcCtD
Fluorouracil—Arrhythmia—Epirubicin—uterine cancer	8.09e-05	0.000622	CcSEcCtD
Fluorouracil—Alopecia—Epirubicin—uterine cancer	8e-05	0.000615	CcSEcCtD
Fluorouracil—Erythema—Epirubicin—uterine cancer	7.88e-05	0.000606	CcSEcCtD
Fluorouracil—Diarrhoea—Etoposide—uterine cancer	7.85e-05	0.000604	CcSEcCtD
Fluorouracil—Dizziness—Etoposide—uterine cancer	7.59e-05	0.000583	CcSEcCtD
Fluorouracil—Arrhythmia—Doxorubicin—uterine cancer	7.49e-05	0.000575	CcSEcCtD
Fluorouracil—Vision blurred—Epirubicin—uterine cancer	7.43e-05	0.000571	CcSEcCtD
Fluorouracil—Alopecia—Doxorubicin—uterine cancer	7.41e-05	0.000569	CcSEcCtD
Fluorouracil—Vomiting—Etoposide—uterine cancer	7.3e-05	0.000561	CcSEcCtD
Fluorouracil—Erythema—Doxorubicin—uterine cancer	7.3e-05	0.000561	CcSEcCtD
Fluorouracil—Anaemia—Epirubicin—uterine cancer	7.29e-05	0.00056	CcSEcCtD
Fluorouracil—Rash—Etoposide—uterine cancer	7.24e-05	0.000556	CcSEcCtD
Fluorouracil—Dermatitis—Etoposide—uterine cancer	7.23e-05	0.000556	CcSEcCtD
Fluorouracil—Headache—Etoposide—uterine cancer	7.19e-05	0.000553	CcSEcCtD
Fluorouracil—Leukopenia—Epirubicin—uterine cancer	7.06e-05	0.000542	CcSEcCtD
Fluorouracil—Vision blurred—Doxorubicin—uterine cancer	6.88e-05	0.000528	CcSEcCtD
Fluorouracil—Convulsion—Epirubicin—uterine cancer	6.83e-05	0.000525	CcSEcCtD
Fluorouracil—Nausea—Etoposide—uterine cancer	6.82e-05	0.000524	CcSEcCtD
Fluorouracil—Anaemia—Doxorubicin—uterine cancer	6.74e-05	0.000518	CcSEcCtD
Fluorouracil—Chest pain—Epirubicin—uterine cancer	6.71e-05	0.000516	CcSEcCtD
Fluorouracil—Myalgia—Epirubicin—uterine cancer	6.71e-05	0.000516	CcSEcCtD
Fluorouracil—Discomfort—Epirubicin—uterine cancer	6.63e-05	0.00051	CcSEcCtD
Fluorouracil—Leukopenia—Doxorubicin—uterine cancer	6.53e-05	0.000502	CcSEcCtD
Fluorouracil—Confusional state—Epirubicin—uterine cancer	6.49e-05	0.000499	CcSEcCtD
Fluorouracil—Anaphylactic shock—Epirubicin—uterine cancer	6.44e-05	0.000495	CcSEcCtD
Fluorouracil—Oedema—Epirubicin—uterine cancer	6.44e-05	0.000495	CcSEcCtD
Fluorouracil—Infection—Epirubicin—uterine cancer	6.39e-05	0.000491	CcSEcCtD
Fluorouracil—Convulsion—Doxorubicin—uterine cancer	6.32e-05	0.000486	CcSEcCtD
Fluorouracil—Nervous system disorder—Epirubicin—uterine cancer	6.31e-05	0.000485	CcSEcCtD
Fluorouracil—Thrombocytopenia—Epirubicin—uterine cancer	6.3e-05	0.000484	CcSEcCtD
Fluorouracil—Tachycardia—Epirubicin—uterine cancer	6.28e-05	0.000483	CcSEcCtD
Fluorouracil—Chest pain—Doxorubicin—uterine cancer	6.21e-05	0.000477	CcSEcCtD
Fluorouracil—Myalgia—Doxorubicin—uterine cancer	6.21e-05	0.000477	CcSEcCtD
Fluorouracil—Discomfort—Doxorubicin—uterine cancer	6.14e-05	0.000472	CcSEcCtD
Fluorouracil—Anorexia—Epirubicin—uterine cancer	6.13e-05	0.000471	CcSEcCtD
Fluorouracil—Hypotension—Epirubicin—uterine cancer	6.01e-05	0.000462	CcSEcCtD
Fluorouracil—Confusional state—Doxorubicin—uterine cancer	6e-05	0.000461	CcSEcCtD
Fluorouracil—Oedema—Doxorubicin—uterine cancer	5.95e-05	0.000458	CcSEcCtD
Fluorouracil—Anaphylactic shock—Doxorubicin—uterine cancer	5.95e-05	0.000458	CcSEcCtD
Fluorouracil—Infection—Doxorubicin—uterine cancer	5.92e-05	0.000455	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Epirubicin—uterine cancer	5.86e-05	0.000451	CcSEcCtD
Fluorouracil—Nervous system disorder—Doxorubicin—uterine cancer	5.84e-05	0.000449	CcSEcCtD
Fluorouracil—Thrombocytopenia—Doxorubicin—uterine cancer	5.83e-05	0.000448	CcSEcCtD
Fluorouracil—Insomnia—Epirubicin—uterine cancer	5.82e-05	0.000447	CcSEcCtD
Fluorouracil—Tachycardia—Doxorubicin—uterine cancer	5.81e-05	0.000447	CcSEcCtD
Fluorouracil—Paraesthesia—Epirubicin—uterine cancer	5.78e-05	0.000444	CcSEcCtD
Fluorouracil—Dyspnoea—Epirubicin—uterine cancer	5.74e-05	0.000441	CcSEcCtD
Fluorouracil—Somnolence—Epirubicin—uterine cancer	5.72e-05	0.00044	CcSEcCtD
Fluorouracil—Anorexia—Doxorubicin—uterine cancer	5.68e-05	0.000436	CcSEcCtD
Fluorouracil—Dyspepsia—Epirubicin—uterine cancer	5.66e-05	0.000435	CcSEcCtD
Fluorouracil—Decreased appetite—Epirubicin—uterine cancer	5.59e-05	0.00043	CcSEcCtD
Fluorouracil—Hypotension—Doxorubicin—uterine cancer	5.56e-05	0.000428	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Epirubicin—uterine cancer	5.56e-05	0.000427	CcSEcCtD
Fluorouracil—Pain—Epirubicin—uterine cancer	5.5e-05	0.000423	CcSEcCtD
Fluorouracil—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.42e-05	0.000417	CcSEcCtD
Fluorouracil—Insomnia—Doxorubicin—uterine cancer	5.39e-05	0.000414	CcSEcCtD
Fluorouracil—Paraesthesia—Doxorubicin—uterine cancer	5.35e-05	0.000411	CcSEcCtD
Fluorouracil—Dyspnoea—Doxorubicin—uterine cancer	5.31e-05	0.000408	CcSEcCtD
Fluorouracil—Feeling abnormal—Epirubicin—uterine cancer	5.3e-05	0.000408	CcSEcCtD
Fluorouracil—Somnolence—Doxorubicin—uterine cancer	5.29e-05	0.000407	CcSEcCtD
Fluorouracil—Dyspepsia—Doxorubicin—uterine cancer	5.24e-05	0.000403	CcSEcCtD
Fluorouracil—Decreased appetite—Doxorubicin—uterine cancer	5.18e-05	0.000398	CcSEcCtD
Fluorouracil—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.14e-05	0.000395	CcSEcCtD
Fluorouracil—Urticaria—Epirubicin—uterine cancer	5.11e-05	0.000393	CcSEcCtD
Fluorouracil—Pain—Doxorubicin—uterine cancer	5.09e-05	0.000391	CcSEcCtD
Fluorouracil—Body temperature increased—Epirubicin—uterine cancer	5.09e-05	0.000391	CcSEcCtD
Fluorouracil—Feeling abnormal—Doxorubicin—uterine cancer	4.91e-05	0.000377	CcSEcCtD
Fluorouracil—Hypersensitivity—Epirubicin—uterine cancer	4.74e-05	0.000364	CcSEcCtD
Fluorouracil—Urticaria—Doxorubicin—uterine cancer	4.73e-05	0.000364	CcSEcCtD
Fluorouracil—Body temperature increased—Doxorubicin—uterine cancer	4.71e-05	0.000362	CcSEcCtD
Fluorouracil—Pruritus—Epirubicin—uterine cancer	4.55e-05	0.00035	CcSEcCtD
Fluorouracil—Diarrhoea—Epirubicin—uterine cancer	4.4e-05	0.000338	CcSEcCtD
Fluorouracil—Hypersensitivity—Doxorubicin—uterine cancer	4.39e-05	0.000337	CcSEcCtD
Fluorouracil—Dizziness—Epirubicin—uterine cancer	4.26e-05	0.000327	CcSEcCtD
Fluorouracil—Pruritus—Doxorubicin—uterine cancer	4.21e-05	0.000324	CcSEcCtD
Fluorouracil—Vomiting—Epirubicin—uterine cancer	4.09e-05	0.000314	CcSEcCtD
Fluorouracil—Diarrhoea—Doxorubicin—uterine cancer	4.07e-05	0.000313	CcSEcCtD
Fluorouracil—Rash—Epirubicin—uterine cancer	4.06e-05	0.000312	CcSEcCtD
Fluorouracil—Dermatitis—Epirubicin—uterine cancer	4.05e-05	0.000312	CcSEcCtD
Fluorouracil—Headache—Epirubicin—uterine cancer	4.03e-05	0.00031	CcSEcCtD
Fluorouracil—Dizziness—Doxorubicin—uterine cancer	3.94e-05	0.000303	CcSEcCtD
Fluorouracil—Nausea—Epirubicin—uterine cancer	3.82e-05	0.000294	CcSEcCtD
Fluorouracil—Vomiting—Doxorubicin—uterine cancer	3.79e-05	0.000291	CcSEcCtD
Fluorouracil—Rash—Doxorubicin—uterine cancer	3.75e-05	0.000289	CcSEcCtD
Fluorouracil—Dermatitis—Doxorubicin—uterine cancer	3.75e-05	0.000288	CcSEcCtD
Fluorouracil—Headache—Doxorubicin—uterine cancer	3.73e-05	0.000287	CcSEcCtD
Fluorouracil—Nausea—Doxorubicin—uterine cancer	3.54e-05	0.000272	CcSEcCtD
Fluorouracil—TYMS—Metabolism—DCN—uterine cancer	2.66e-05	0.000365	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKR1C3—uterine cancer	2.65e-05	0.000365	CbGpPWpGaD
Fluorouracil—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.65e-05	0.000365	CbGpPWpGaD
Fluorouracil—ALB—Platelet degranulation—VEGFA—uterine cancer	2.64e-05	0.000363	CbGpPWpGaD
Fluorouracil—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.61e-05	0.00036	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	2.59e-05	0.000356	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CDKN2B—uterine cancer	2.54e-05	0.00035	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKR1C1—uterine cancer	2.54e-05	0.00035	CbGpPWpGaD
Fluorouracil—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	2.52e-05	0.000346	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CYP11A1—uterine cancer	2.5e-05	0.000344	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.46e-05	0.000338	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.44e-05	0.000336	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.44e-05	0.000336	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.43e-05	0.000334	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKR1B1—uterine cancer	2.39e-05	0.000328	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—STAR—uterine cancer	2.39e-05	0.000328	CbGpPWpGaD
Fluorouracil—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.38e-05	0.000328	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—STK11—uterine cancer	2.37e-05	0.000327	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—CYP19A1—uterine cancer	2.37e-05	0.000327	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKR1C3—uterine cancer	2.36e-05	0.000325	CbGpPWpGaD
Fluorouracil—ALB—Folate Metabolism—TP53—uterine cancer	2.33e-05	0.00032	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—SMAD3—uterine cancer	2.32e-05	0.000319	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.31e-05	0.000318	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.31e-05	0.000318	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—PIK3CA—uterine cancer	2.31e-05	0.000318	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—RRM2—uterine cancer	2.26e-05	0.000312	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—FGFR2—uterine cancer	2.21e-05	0.000305	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN2B—uterine cancer	2.21e-05	0.000304	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—DCN—uterine cancer	2.2e-05	0.000302	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDKN2A—uterine cancer	2.2e-05	0.000302	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.18e-05	0.000299	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKR1B1—uterine cancer	2.17e-05	0.000298	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—STAR—uterine cancer	2.17e-05	0.000298	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—PIK3CA—uterine cancer	2.15e-05	0.000296	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—PIK3CA—uterine cancer	2.15e-05	0.000296	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PTEN—uterine cancer	2.11e-05	0.00029	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PTEN—uterine cancer	2.11e-05	0.00029	CbGpPWpGaD
Fluorouracil—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.08e-05	0.000286	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP11A1—uterine cancer	2.07e-05	0.000285	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—CYP19A1—uterine cancer	2.07e-05	0.000284	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—STK11—uterine cancer	2.07e-05	0.000284	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.05e-05	0.000282	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.05e-05	0.000282	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—IRF1—uterine cancer	2.04e-05	0.000281	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—NDUFB11—uterine cancer	2.04e-05	0.00028	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—SRD5A2—uterine cancer	2.04e-05	0.00028	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	2.02e-05	0.000278	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—SMAD3—uterine cancer	2.02e-05	0.000278	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—EP300—uterine cancer	2.01e-05	0.000277	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—EP300—uterine cancer	2.01e-05	0.000277	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.99e-05	0.000274	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.99e-05	0.000273	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.98e-05	0.000272	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKR1C3—uterine cancer	1.96e-05	0.000269	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—CDKN1B—uterine cancer	1.94e-05	0.000268	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—FGFR2—uterine cancer	1.93e-05	0.000265	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle, Mitotic—EP300—uterine cancer	1.91e-05	0.000263	CbGpPWpGaD
Fluorouracil—UMPS—Metabolism—AKT1—uterine cancer	1.89e-05	0.00026	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.88e-05	0.000259	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—POLD1—uterine cancer	1.87e-05	0.000258	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.87e-05	0.000257	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—MTHFR—uterine cancer	1.85e-05	0.000255	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—STK11—uterine cancer	1.84e-05	0.000253	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—CYP19A1—uterine cancer	1.84e-05	0.000253	CbGpPWpGaD
Fluorouracil—UPP1—Metabolism—AKT1—uterine cancer	1.76e-05	0.000242	CbGpPWpGaD
Fluorouracil—UPP2—Metabolism—AKT1—uterine cancer	1.76e-05	0.000242	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKR1C1—uterine cancer	1.75e-05	0.000241	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—EP300—uterine cancer	1.71e-05	0.000235	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—POLD1—uterine cancer	1.7e-05	0.000234	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.7e-05	0.000234	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.67e-05	0.000229	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.67e-05	0.000229	CbGpPWpGaD
Fluorouracil—ABCC4—Platelet activation, signaling and aggregation—AKT1—uterine cancer	1.65e-05	0.000227	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.62e-05	0.000223	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKR1C1—uterine cancer	1.59e-05	0.000219	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—RRM2—uterine cancer	1.56e-05	0.000215	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—MTHFR—uterine cancer	1.55e-05	0.000214	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.53e-05	0.00021	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—STK11—uterine cancer	1.52e-05	0.00021	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—CYP19A1—uterine cancer	1.52e-05	0.00021	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—DCN—uterine cancer	1.52e-05	0.000209	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PTEN—uterine cancer	1.5e-05	0.000207	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—PIK3CA—uterine cancer	1.49e-05	0.000205	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—PIK3CA—uterine cancer	1.49e-05	0.000205	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—STAR—uterine cancer	1.48e-05	0.000204	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.48e-05	0.000204	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—STAR—uterine cancer	1.47e-05	0.000203	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKR1B1—uterine cancer	1.47e-05	0.000203	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.46e-05	0.000201	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.46e-05	0.0002	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—EP300—uterine cancer	1.43e-05	0.000197	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.43e-05	0.000197	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP11A1—uterine cancer	1.43e-05	0.000196	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.42e-05	0.000196	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.42e-05	0.000196	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—RRM2—uterine cancer	1.42e-05	0.000195	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—EP300—uterine cancer	1.41e-05	0.000194	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—ERBB2—uterine cancer	1.39e-05	0.000191	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.38e-05	0.00019	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—MTHFR—uterine cancer	1.38e-05	0.00019	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—DCN—uterine cancer	1.38e-05	0.000189	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.36e-05	0.000188	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKR1C3—uterine cancer	1.35e-05	0.000186	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—VEGFA—uterine cancer	1.33e-05	0.000184	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—NRAS—uterine cancer	1.32e-05	0.000181	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.31e-05	0.00018	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.3e-05	0.000179	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CDKN1B—uterine cancer	1.29e-05	0.000177	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.22e-05	0.000169	CbGpPWpGaD
Fluorouracil—TYMS—Cell Cycle—TP53—uterine cancer	1.22e-05	0.000168	CbGpPWpGaD
Fluorouracil—PPAT—Metabolism—AKT1—uterine cancer	1.22e-05	0.000167	CbGpPWpGaD
Fluorouracil—DPYD—Metabolism—AKT1—uterine cancer	1.22e-05	0.000167	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—CTNNB1—uterine cancer	1.22e-05	0.000167	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—ERBB2—uterine cancer	1.21e-05	0.000166	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.21e-05	0.000166	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—STAR—uterine cancer	1.21e-05	0.000166	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.19e-05	0.000164	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PTEN—uterine cancer	1.18e-05	0.000163	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.17e-05	0.000161	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—POLD1—uterine cancer	1.16e-05	0.00016	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—POLD1—uterine cancer	1.16e-05	0.000159	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—MTHFR—uterine cancer	1.14e-05	0.000158	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—KRAS—uterine cancer	1.13e-05	0.000156	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—EP300—uterine cancer	1.13e-05	0.000156	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CDKN1B—uterine cancer	1.12e-05	0.000154	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.09e-05	0.00015	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKR1C1—uterine cancer	1.08e-05	0.000149	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—PIK3CA—uterine cancer	1.06e-05	0.000146	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—CTNNB1—uterine cancer	1.06e-05	0.000146	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—NRAS—uterine cancer	1.06e-05	0.000145	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—STK11—uterine cancer	1.05e-05	0.000145	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—CYP19A1—uterine cancer	1.05e-05	0.000145	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—PIK3CA—uterine cancer	1.04e-05	0.000143	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PTEN—uterine cancer	1.03e-05	0.000142	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.03e-05	0.000142	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—STAR—uterine cancer	1.03e-05	0.000142	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.02e-05	0.00014	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.01e-05	0.000139	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—TP53—uterine cancer	1.01e-05	0.000139	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PTEN—uterine cancer	9.92e-06	0.000137	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—EP300—uterine cancer	9.84e-06	0.000135	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—RRM2—uterine cancer	9.69e-06	0.000133	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—HRAS—uterine cancer	9.64e-06	0.000133	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—RRM2—uterine cancer	9.63e-06	0.000133	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—CYP19A1—uterine cancer	9.54e-06	0.000131	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—STK11—uterine cancer	9.54e-06	0.000131	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—EP300—uterine cancer	9.46e-06	0.00013	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—POLD1—uterine cancer	9.46e-06	0.00013	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—DCN—uterine cancer	9.4e-06	0.000129	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—DCN—uterine cancer	9.35e-06	0.000129	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—NRAS—uterine cancer	9.2e-06	0.000127	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	9.15e-06	0.000126	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—KRAS—uterine cancer	9.1e-06	0.000125	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP11A1—uterine cancer	8.86e-06	0.000122	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKR1C1—uterine cancer	8.85e-06	0.000122	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP11A1—uterine cancer	8.81e-06	0.000121	CbGpPWpGaD
Fluorouracil—TYMP—Metabolism—AKT1—uterine cancer	8.67e-06	0.000119	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PTEN—uterine cancer	8.64e-06	0.000119	CbGpPWpGaD
Fluorouracil—ABCC4—Hemostasis—AKT1—uterine cancer	8.51e-06	0.000117	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKR1C3—uterine cancer	8.37e-06	0.000115	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—PIK3CA—uterine cancer	8.36e-06	0.000115	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKR1C3—uterine cancer	8.32e-06	0.000114	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—EP300—uterine cancer	8.24e-06	0.000113	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—POLD1—uterine cancer	8.08e-06	0.000111	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—KRAS—uterine cancer	7.92e-06	0.000109	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—MTHFR—uterine cancer	7.89e-06	0.000109	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—RRM2—uterine cancer	7.88e-06	0.000109	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—HRAS—uterine cancer	7.73e-06	0.000106	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PTEN—uterine cancer	7.69e-06	0.000106	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—DCN—uterine cancer	7.65e-06	0.000105	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKR1C1—uterine cancer	7.56e-06	0.000104	CbGpPWpGaD
Fluorouracil—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	7.47e-06	0.000103	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—EP300—uterine cancer	7.34e-06	0.000101	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—PIK3CA—uterine cancer	7.28e-06	0.0001	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP11A1—uterine cancer	7.21e-06	9.92e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—MTHFR—uterine cancer	7.17e-06	9.87e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—PIK3CA—uterine cancer	7e-06	9.63e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Disease—AKT1—uterine cancer	6.83e-06	9.4e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKR1C3—uterine cancer	6.81e-06	9.37e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—RRM2—uterine cancer	6.74e-06	9.27e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—HRAS—uterine cancer	6.73e-06	9.27e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—DCN—uterine cancer	6.54e-06	9e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—STK11—uterine cancer	6.52e-06	8.97e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—CYP19A1—uterine cancer	6.52e-06	8.97e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—STK11—uterine cancer	6.48e-06	8.92e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—CYP19A1—uterine cancer	6.48e-06	8.92e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—EP300—uterine cancer	6.37e-06	8.77e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PTEN—uterine cancer	6.37e-06	8.76e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.16e-06	8.48e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.12e-06	8.42e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—PIK3CA—uterine cancer	6.09e-06	8.39e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.08e-06	8.37e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—EP300—uterine cancer	6.07e-06	8.36e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—VEGFA—uterine cancer	6.04e-06	8.31e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—NRAS—uterine cancer	5.96e-06	8.21e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Disease—AKT1—uterine cancer	5.94e-06	8.18e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.84e-06	8.03e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKR1C3—uterine cancer	5.82e-06	8.01e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.8e-06	7.99e-05	CbGpPWpGaD
Fluorouracil—MTHFR—Metabolism—AKT1—uterine cancer	5.72e-06	7.87e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—PIK3CA—uterine cancer	5.43e-06	7.47e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—CYP19A1—uterine cancer	5.31e-06	7.3e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—STK11—uterine cancer	5.31e-06	7.3e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—KRAS—uterine cancer	5.13e-06	7.06e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.98e-06	6.85e-05	CbGpPWpGaD
Fluorouracil—ABCC5—Metabolism—AKT1—uterine cancer	4.98e-06	6.85e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—MTHFR—uterine cancer	4.9e-06	6.74e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—MTHFR—uterine cancer	4.87e-06	6.7e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.75e-06	6.54e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—PIK3CA—uterine cancer	4.71e-06	6.49e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—TP53—uterine cancer	4.56e-06	6.28e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—STK11—uterine cancer	4.53e-06	6.24e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.53e-06	6.24e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—PIK3CA—uterine cancer	4.49e-06	6.18e-05	CbGpPWpGaD
Fluorouracil—TYMS—Metabolism—AKT1—uterine cancer	4.43e-06	6.1e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PTEN—uterine cancer	4.39e-06	6.04e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—HRAS—uterine cancer	4.36e-06	6e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.32e-06	5.94e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.29e-06	5.91e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.26e-06	5.86e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—EP300—uterine cancer	4.19e-06	5.76e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.06e-06	5.59e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PTEN—uterine cancer	3.99e-06	5.49e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—MTHFR—uterine cancer	3.99e-06	5.49e-05	CbGpPWpGaD
Fluorouracil—ALB—Hemostasis—AKT1—uterine cancer	3.85e-06	5.3e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—EP300—uterine cancer	3.8e-06	5.24e-05	CbGpPWpGaD
Fluorouracil—ABCC3—Metabolism—AKT1—uterine cancer	3.67e-06	5.05e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.51e-06	4.83e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—MTHFR—uterine cancer	3.41e-06	4.69e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—PIK3CA—uterine cancer	3.1e-06	4.26e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3e-06	4.13e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—PIK3CA—uterine cancer	2.81e-06	3.87e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PTEN—uterine cancer	2.73e-06	3.75e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PTEN—uterine cancer	2.71e-06	3.73e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—EP300—uterine cancer	2.6e-06	3.58e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—EP300—uterine cancer	2.58e-06	3.56e-05	CbGpPWpGaD
Fluorouracil—ABCG2—Metabolism—AKT1—uterine cancer	2.53e-06	3.48e-05	CbGpPWpGaD
Fluorouracil—CYP2A6—Metabolism—AKT1—uterine cancer	2.3e-06	3.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PTEN—uterine cancer	2.22e-06	3.05e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—EP300—uterine cancer	2.12e-06	2.91e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—PIK3CA—uterine cancer	1.92e-06	2.65e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—PIK3CA—uterine cancer	1.91e-06	2.63e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PTEN—uterine cancer	1.9e-06	2.61e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—EP300—uterine cancer	1.81e-06	2.49e-05	CbGpPWpGaD
Fluorouracil—CYP2C8—Metabolism—AKT1—uterine cancer	1.57e-06	2.16e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.56e-06	2.15e-05	CbGpPWpGaD
Fluorouracil—ALB—Metabolism—AKT1—uterine cancer	1.56e-06	2.15e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.34e-06	1.84e-05	CbGpPWpGaD
Fluorouracil—CYP2C9—Metabolism—AKT1—uterine cancer	1.28e-06	1.76e-05	CbGpPWpGaD
Fluorouracil—CYP1A2—Metabolism—AKT1—uterine cancer	1.09e-06	1.5e-05	CbGpPWpGaD
